tiprankstipranks
Abbott Laboratories (GB:0Q15)
LSE:0Q15
UK Market

Abbott Laboratories (0Q15) Income Statement

Compare
2 Followers

Abbott Laboratories Income Statement

Last quarter (Q3 2024), Abbott Laboratories's total revenue was $10.63B, an increase of 4.85% from the same quarter last year. In Q3, Abbott Laboratories's net income was $1.65B. See Abbott Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 40.11B$ 43.65B$ 43.08B$ 34.61B$ 31.90B
Gross Profit
$ 22.13B$ 24.51B$ 24.54B$ 19.61B$ 18.67B
Operating Expenses
$ 15.66B$ 16.15B$ 16.11B$ 14.25B$ 14.14B
Depreciation and Amortization
$ 3.24B$ 3.27B$ 3.54B$ 3.33B$ 3.01B
EBITDA
$ 10.61B$ 12.38B$ 12.74B$ 8.79B$ 7.77B
Operating Income
$ 6.48B$ 8.36B$ 8.43B$ 5.36B$ 4.53B
Other Income/Expenses
$ 186.00M$ -56.00M$ -214.00M$ -389.00M$ -455.00M
Pretax Income
$ 6.66B$ 8.31B$ 8.21B$ 4.97B$ 4.08B
Net Income
$ 5.72B$ 6.93B$ 7.07B$ 4.50B$ 3.69B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.30$ 3.94$ 3.97$ 2.52$ 2.07
Diluted EPS
$ 3.27$ 3.91$ 3.94$ 2.50$ 2.06
Weighted Average Shares Outstanding
1.73B 1.75B 1.77B 1.77B 1.77B
Weighted Average Shares Outstanding (Diluted)
1.75B 1.76B 1.79B 1.79B 1.78B
Currency in USD

Abbott Laboratories Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis